We're no longer attracting top talent: the brain drain killing American science

Shifting destinations for researchers (Europe, Canada, elsewhere)

• Some commenters describe moving or considering moves to Ireland, Germany, Switzerland, Canada, and Singapore, citing: easier immigration paths, better social systems, friendlier daily life, and more stable or rising science funding.
• Downsides raised: high taxes, weak infrastructure (e.g. Irish transit), housing crises, and fears that EU research funding still lags US levels.
• Several note that the US is now actively repelling both foreign and domestic scientists through funding cuts, immigration risk, and political hostility.

China and future scientific leadership

• Many see China as the main long‑term science superpower: huge R&D spending, willingness to invest at a loss for decades, strong positions in solar, batteries, fusion, biotech, and AI.
• Others push back: language and cultural barriers, authoritarianism, lack of true immigration or naturalization, and reputational issues make it unattractive for many foreign scientists.
• Debate over how big China’s “effective” talent pool is, given uneven internal development.

Is “brain drain” real, or is there a glut?

• One camp: there is a massive oversupply of biomedical PhDs; tenure‑track odds were already low, and cuts just worsen an unsustainable pyramid. They argue the US is still the “least bad” place for funding and that fewer PhDs plus better support would be healthier.
• Counter‑camp: the real loss is people leaving science entirely or choosing other countries and industries; fewer PhDs would shrink the idea pipeline. They emphasize that other countries are ramping recruitment and funding.

Politics, safety, and academic freedom

• Multiple comments link US science decline to the current administration’s hostility toward academia, targeted cuts (NIH/NSF, social and health research), and culture‑war filters on grants.
• Some scientists now avoid the US over fears about immigration enforcement, civil liberties, and democratic backsliding; others argue Europe is no freer, pointing to hate‑speech laws and speech‑related prosecutions.
• There’s concern that short presidential cycles and wild policy swings make long‑horizon research careers in the US precarious.

Systemic context: healthcare, education, and corporate labs

• Several argue that countries with efficient healthcare and integrated welfare states may ultimately be better places to both do medical research and deploy it.
• Education discussion is split: some defend US K‑12/college quality (especially for majority groups), others note poor literacy rates and growing inequality.
• Many see a long‑term shift from public, open university research toward corporate labs (AI in particular), with whole scientific domains still dependent on public funding and thus especially exposed to US cuts.